Medical Economics, Northfield, IL, welcomed Kristen Mally as the new editor of Pharmaceutical Representative in April. She replaced Laura Ramos, who headed the publication from 1993 to 1997.
Medical Economics, Northfield, IL, welcomed Kristen Mally as the new editor of Pharmaceutical Representative in April. She replaced Laura Ramos, who headed the publication from 1993 to 1997.
Mally, formerly associate editor of the monthly magazine U.S.ART, is also a freelance writer who has authored a wide variety of articles. She has been published in regional business and general interest magazines in Minneapolis, including Twin Cities Business Monthly and Minneapolis/St.Paul Magazine, and has been a volunteer contributor to non-profit newsletters that focus on spina bifida. Among other topics, she has reported on third-party administrators, initial public offerings, art reviews, family issues and boards of directors.
Her plans for Pharmaceutical Representative are straightforward.
"I'd like Pharmaceutical Representative to be the one publication that reps read for industry news, no matter what, even when they don't have time to read anything else," Mally said. "In many ways, the magazine has already become the primary source of industry news - and I hope it will continue to be a powerful information tool for reps - but I'd also like to see it provide more insight as to who reps are, what late-breaking developments they need to know now and how they can prepare for future trends."
An alumna of Georgetown University, Washington, Mally currently lives in Wilmette, IL, where she enjoys running, camping and vegetarian cooking. PR
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.